Personalis, Inc. to Provide Tumor Immunogenomic Profiling to the Parker Institute for Immunotherapy Biomarker Discovery in Clinical Trial Participants
MENLO PARK, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/parkerici?src=hash" target="_blank"gt;#parkericilt;/agt;–Personalis, Inc., a leader in advanced genomics for cancer, today announced that the Parker Institute…